Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Organic Chemistry
|
November 14, 1974
A new synthesis of N alpha,NG,G-tribenzyloxycarbonyl-L-arginine and related derivatives
E L Smithwick, R T Shuman
Pharmaceutical Biotechnology
|
October 7, 1998
Development of an orally active tripeptide arginal thrombin inhibitor
R T Shuman, P D Gesellchen
Analytical Biochemistry
|
June 1, 1977
Use of peptidyl-4-methoxy-2-naphthylamides to assay plasmin
S A Clavin, J L Bobbitt, R T Shuman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1986
Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217
M L Cohen, R T Shuman, J J Osborne, et al.
Journal of Cardiovascular Pharmacology
|
April 1, 1993
Reversible tripeptide thrombin inhibitors as adjunctive agents to coronary thrombolysis: a comparison with heparin in a canine model of coronary artery thrombosis
C V Jackson, H C Wilson, V G Growe, et al.
Journal of Medicinal Chemistry
|
February 5, 1993
Highly selective tripeptide thrombin inhibitors
R T Shuman, R B Rothenberger, C S Campbell, et al.
Journal of Medicinal Chemistry
|
October 27, 1995
Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions
R T Shuman, R B Rothenberger, C S Campbell, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1996
A family of arginal thrombin inhibitors related to efegatran
G F Smith, R T Shuman, T J Craft, et al.
Journal of Medicinal Chemistry
|
June 8, 2000
Non-amidine-containing 1,2-dibenzamidobenzene inhibitors of human factor Xa with potent anticoagulant and antithrombotic activity
J J Masters, J B Franciskovich, J M Tinsley, et al.
Journal of Medicinal Chemistry
|
March 15, 2000
Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity
M R Wiley, L C Weir, S Briggs, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Organic Chemistry
|
November 14, 1974
A new synthesis of N alpha,NG,G-tribenzyloxycarbonyl-L-arginine and related derivatives
E L Smithwick, R T Shuman
Pharmaceutical Biotechnology
|
October 7, 1998
Development of an orally active tripeptide arginal thrombin inhibitor
R T Shuman, P D Gesellchen
Analytical Biochemistry
|
June 1, 1977
Use of peptidyl-4-methoxy-2-naphthylamides to assay plasmin
S A Clavin, J L Bobbitt, R T Shuman, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1986
Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217
M L Cohen, R T Shuman, J J Osborne, et al.
Journal of Cardiovascular Pharmacology
|
April 1, 1993
Reversible tripeptide thrombin inhibitors as adjunctive agents to coronary thrombolysis: a comparison with heparin in a canine model of coronary artery thrombosis
C V Jackson, H C Wilson, V G Growe, et al.
Journal of Medicinal Chemistry
|
February 5, 1993
Highly selective tripeptide thrombin inhibitors
R T Shuman, R B Rothenberger, C S Campbell, et al.
Journal of Medicinal Chemistry
|
October 27, 1995
Structure-activity study of tripeptide thrombin inhibitors using alpha-alkyl amino acids and other conformationally constrained amino acid substitutions
R T Shuman, R B Rothenberger, C S Campbell, et al.
Seminars in Thrombosis and Hemostasis
|
January 1, 1996
A family of arginal thrombin inhibitors related to efegatran
G F Smith, R T Shuman, T J Craft, et al.
Journal of Medicinal Chemistry
|
June 8, 2000
Non-amidine-containing 1,2-dibenzamidobenzene inhibitors of human factor Xa with potent anticoagulant and antithrombotic activity
J J Masters, J B Franciskovich, J M Tinsley, et al.
Journal of Medicinal Chemistry
|
March 15, 2000
Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity
M R Wiley, L C Weir, S Briggs, et al.
Page
of 1